By Erica Teichert ( March 8, 2013, 7:09 PM EST) -- Glenmark Pharmaceuticals Ltd. on Friday slammed Abbott Laboratories' blood pressure drug Tarka as a "commercial disaster" that never should have received patent protection because of thousands of similar treatment combinations, urging a Federal Circuit panel to nix the patent and the company's $16 million infringement win....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.